The Niclosavir team has successfully reformulated an existing drug to unlock its potential therapeutic properties that can address key health challenges in both humans and animals. Niclosavir is the result of breakthrough research into an old drug, niclosamide, discovered in the 1950s as a treatme...See more
Headquarters:
New Zealand
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2022 (4 years)
Address:
HAWKES BAY, 4130, NZ
LOW
spending power
